PLLR labeling final rule. U.S. food and drug administration.

() ()Vestergaard C. Wollenberg A. Barbarot S. et al.

European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period.

J Eur Acad Dermatol Venereol. 33: 1644-1659

Allergic contact dermatitis.

Med Clin North Am. 104: 61-76Zuberbier T. Aberer W. Asero R. et al.

The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.

Allergy. 73: 1393-1414Saini S. Shams M. Bernstein J.A. et al.

Urticaria and angioedema across the ages.

J Allergy Clin Immunol Pract. 8: 1866-1874Saini S. Rosen K.E. Hsieh H.J. et al.

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.

J Allergy Clin Immunol. 128: 567-573.e1Grattan C.E. O'Donnell B.F. Francis D.M. et al.

Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria.

Br J Dermatol. 143: 365-372Napolitano M. Ruggiero A. Fontanella G. et al.

New emergent therapies for atopic dermatitis: a review of safety profile with respect to female fertility, pregnancy, and breastfeeding.

Dermatol Ther. 34: e14475Mian M. Dunlap R. Simpson E.

Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: a case report.

JAAD Case Rep. 6: 1051-1052Kanda N. Hoashi T. Saeki H.

The roles of sex hormones in the course of atopic dermatitis.

Int J Mol Sci. 20https://doi.org/10.3390/ijms20194660Weatherhead S. Robson S.C. Reynolds N.J.

Eczema in pregnancy.

BMJ. 335: 152-154Gonzalez-Estrada A. Geraci S.A.

Allergy medications during pregnancy.

Am J Med Sci. 352: 326-331

Novel systemic treatments in atopic dermatitis: are there sex differences?.

Int J Women’s Dermatol. 7: 606-614Rakita U. Kaundinya T. Silverberg J.I.

Lack of association between atopic dermatitis severity and worsening during pregnancy: a cross-sectional study.

J Am Acad Dermatol. https://doi.org/10.1016/j.jaad.2021.09.066Hamann C.R. Egeberg A. Wollenberg A. et al.

Pregnancy complications, treatment characteristics and birth outcomes in women with atopic dermatitis in Denmark.

J Eur Acad Dermatol Venereol. 33: 577-587Murase J.E. Heller M.M. Butler D.C.

Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy.

J Am Acad Dermatol. 70 (): 401.e1-14Reitamo S. Wollenberg A. Schöpf E. et al.

Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European tacrolimus ointment study group.

Arch Dermatol. 136: 999-1006Draelos Z. Nayak A. Pariser D. et al.

Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison.

J Am Acad Dermatol. 53: 602-609Cartron A.M. Nguyen T.H. Roh Y.S. et al.

Janus kinase inhibitors for atopic dermatitis: a promising treatment modality.

Clin Exp Dermatol. 46: 820-824Dadashi M. Hajikhani B. Darban-Sarokhalil D. et al.

Mupirocin resistance in Staphylococcus aureus: a systematic review and meta-analysis.

J Glob Antimicrob Resist. 20: 238-247El-Saie L.T. Rabie A.R. Kamel M.I. et al.

Effect of narrowband ultraviolet B phototherapy on serum folic acid levels in patients with psoriasis.

Lasers Med Sci. 26: 481-485Akbari M. Shah S. Velayos F.S. et al.

Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease.

Inflamm Bowel Dis. 19: 15-22

Histamine and H1-antihistamines: celebrating a century of progress.

J Allergy Clin Immunol. 128 (): 1139-1150Lobo Y. Lee R.C. Spelman L.

Atopic dermatitis treated safely with dupilumab during pregnancy: a case report and review of the literature.

Case Rep Dermatol. 13: 248-256Wollenberg A. Blauvelt A. Guttman-Yassky E. et al.

Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).

Br J Dermatol. 184: 437-449Zuberbier T. Abdul Latiff A.H. Abuzakouk M. et al.

The International EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.

Allergy. https://doi.org/10.1111/all.15090Kolkhir P. Borzova E. Grattan C. et al.

Autoimmune comorbidity in chronic spontaneous urticaria: a systematic review.

Autoimmun Rev. 16: 1196-1208Kocatürk E. Al-Ahmad M. Krause K. et al.

Effects of pregnancy on chronic urticaria: results of the PREG-CU UCARE study.

Allergy. 76: 3133-3144Fricke J. Ávila G. Keller T. et al.

Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis.

Allergy. 75: 423-432Zhong H. Song Z. Chen W. et al.

Chronic urticaria in Chinese population: a hospital-based multicenter epidemiological study.

Allergy. 69: 359-364Maurer M. Ortonne J.P. Zuberbier T.

Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients.

Br J Dermatol. 160: 633-641Gregoriou S. Rigopoulos D. Katsambas A. et al.

Etiologic aspects and prognostic factors of patients with chronic urticaria: nonrandomized, prospective, descriptive study.

J Cutan Med Surg. 13: 198-203Sánchez Borges M. Tassinari S. Flores A.

[Epidemiologic features in patients with antihistamine-resistant chronic urticaria].

Rev Alerg Mex. 62 (): 279-286Straesser M.D. Oliver E. Palacios T. et al.

Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria.

J Allergy Clin Immunol Pract. 6: 1386-1388.e1Pierdominici M. Maselli A. Colasanti T. et al.

Estrogen receptor profiles in human peripheral blood lymphocytes.

Immunol Lett. 132: 79-85Kay A.B. Clark P. Maurer M. et al.

Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous ('idiopathic') urticaria.

Br J Dermatol. 172: 1294-1302Kay A.B. Ying S. Ardelean E. et al.

Calcitonin gene-related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria.

Clin Exp Allergy. 44: 1053-1060Giménez-Arnau A.M. DeMontojoye L. Asero R. et al.

The pathogenesis of chronic spontaneous urticaria: the role of infiltrating cells.

J Allergy Clin Immunol Pract. 9: 2195-2208

Sex, symptom severity, and quality of life in rheumatology.

Clin Rev Allergy Immunol. 56: 346-361Maurer M. Eyerich K. Eyerich S. et al.

Urticaria: Collegium Internationale Allergologicum (CIA) update 2020.

Int Arch Allergy Immunol. 181: 321-333Asero R. Marzano A.V. Ferrucci S. et al.

Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria.

Clin Exp Immunol. 200: 242-249Ying S. Kikuchi Y. Meng Q. et al.

TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction.

J Allergy Clin Immunol. 109: 694-700Shakouri A. Compalati E. Lang D.M. et al.

Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the grading of recommendations assessment, development, and evaluation system.

Curr Opin Allergy Clin Immunol. 10: 362-369Robertson S.A. Care A.S. Moldenhauer L.M.

Regulatory T cells in embryo implantation and the immune response to pregnancy.

J Clin Invest. 128: 4224-4235Murase J.E. Chan K.K. Garite T.J. et al.

Hormonal effect on psoriasis in pregnancy and post partum.

Arch Dermatol. 141: 601-606Woidacki K. Zenclussen A.C. Siebenhaar F.

Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome?.

Front Immunol. 5: 231Cocchiara R. Albeggiani G. Di Trapani G. et al.

Modulation of rat peritoneal mast cell and human basophil histamine release by estrogens.

Int Arch Allergy Appl Immunol. 93: 192-197Woidacki K. Popovic M. Metz M. et al.

Mast cells rescue implantation defects caused by c-kit deficiency.

Cell Death Dis. 4: e462Zaitsu M. Narita S. Lambert K.C. et al.

Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx.

Mol Immunol. 44: 1977-1985Narita S. Goldblum R.M. Watson C.S. et al.

Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators.

Environ Health Perspect. 115: 48-52Kasperska-Zajac A. Brzoza Z. Rogala B.

Lower serum concentration of dehydroepiandrosterone sulphate in patients suffering from chronic idiopathic urticaria.

Allergy. 61: 1489-1490Choi I.S. Cui Y. Koh Y.A. et al.

Effects of dehydroepiandrosterone on Th2 cytokine production in peripheral blood mononuclear cells from asthmatics.

Korean J Intern Med. 23: 176-181

Urticaria and angioedema in pregnancy and lactation.

Immunol Allergy Clin N Am. 34: 149-156Beissert S. Ständer H. Schwarz T.

UVA rush hardening for the treatment of solar urticaria.

J Am Acad Dermatol. 42: 1030-1032Kowalski M.L. Woessner K. Sanak M.

Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema.

J Allergy Clin Immunol. 136: 245-251Powell R.J. Leech S.C. Till S. et al.

BSACI guideline for the management of chronic urticaria and angioedema.

Clin Exp Allergy. 45: 547-565Bousquet J. Khaltaev N. Cruz A.A. et al.

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).

Allergy. 63: 8-160Viegas L.P. Ferreira M.B. Kaplan A.P.

The maddening itch: an approach to chronic urticaria.

J Investig Allergol Clin Immunol. 24: 1-5Maurer M. Altrichter S. Bieber T. et al.

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.

J Allergy Clin Immunol. 128 (): 202-209Metz M. Vadasz Z. Kocatürk E. et al.

Omalizumab updosing in chronic spontaneous urticaria: an overview of real-world evidence.

Clin Rev Allergy Immunol. 59: 38-45Vena G.A. Cassano N. Colombo D. et al.

Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial.

J Am Acad Dermatol. 55: 705-709Zuberbier T. Iffländer J. Semmler C. et al.

Acute urticaria: clinical aspects and therapeutic responsiveness.

Acta Derm Venereol. 76: 295-297

A summary of the new International EAACI/GA2LEN/EDF/WAO guidelines in urticaria.

World Allergy Organ J. 5: S1-S5

Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses.

J Eur Acad Dermatol Venereol. 26: 9-18Powell R.J. Du Toit G.L. Siddique N. et al.

BSACI guidelines for the management of chronic urticaria and angio-oedema.

Clin Exp Allergy. 37: 631-650Akenroye A.T. McEwan C. Saini S.S.

Montelukast reduces symptom severity and frequency in patients with angioedema-predominant chronic spontaneous urticaria.

J Allergy Clin Immunol Pract. 6: 1403-1405Kaplan A. Ledford D. Ashby M. et al.

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.

J Allergy Clin Immunol. 132: 101-109Bundhoo A. Paveglio S. Rafti E. et al.

Evidence that FcRn mediates the transplacental passage of maternal IgE in the form of IgG anti-IgE/IgE immune complexes.

Clin Exp Allergy. 45: 1085-1098Namazy J.A. Blais L. Andrews E.B. et al.

Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort.

J Allergy Clin Immunol. 145: 528-536.e1Fonacier L. Bernstein D.I. Pacheco K. et al.

Contact dermatitis: a practice parameter-update 2015.

J Allergy Clin Immunol Pract. 3: S1-S39Mowad C.M. Anderson B. Scheinman P. et al.

Allergic contact dermatitis: patient diagnosis and evaluation.

J Am Acad Dermatol. 74: 1029-1040